Ausgewählte Publikationen

Nach dem Gesetz ist es uns verboten, die pdf-Dateien der letzen Veröffenlichungen auf unserer Webseite zu präsentieren.
Bitte kontaktieren Sie uns
direkt, wenn Sie an einer Neuauflage interessiert sind. Danke.

2013

Petzold C, Schallenberg S, Stern JNH, Kretschmer K.
Promoting immunological tolerance through targeting dendritic cells.
Rev Diabet Stud. 2013. 9(4):305. Review.

Petzold C, Riewaldt J, Watts D, Sparwasser T, Schallenberg S, Kretschmer K.
Foxp3+ regulatory T cells in mouse models of type 1 diabetes.
J Diabetes Res. 2013. 2013:940710. (PubMed)

Schallenberg, S, Petzold S, Riewaldt J, Kretschmer K.
Regulatory T Cell-Based Immunotherapy: Prospects of Antigen-Specific Tolerance Induction.
In: Medical Advancements in Aging and Regenerative Technologies: Clinical Tools and Applications, ed. A. Daskalaki. 2013. IGI Global, pp. 112-136.

2012

Heninger AK, Theil A, Wilhelm C, Petzold C, Huebel N, Kretschmer K, Bonifacio E, Monti P.
IL-7 abrogates suppressive activity of human CD4+CD25+FOXP3+ regulatory T cells and allows expansion of alloreactive and autoreactive T cells.
J Immunol. 2012. 189(12):5649-58. (PubMed)

Schallenberg S, Petzold C, Tsai PY, Sparwasser T, Kretschmer K.
Vagaries of fluorochrome reporter gene expression in Foxp3+ regulatory T cells.
PLoS One. 2012. 7(8):e41971. (PubMed)

2010

Stern JN†*, Keskin DB, Kato Z, Waldner H, Schallenberg S, Anderson A, von Boehmer H, Kretschmer K†*, Strominger JL†.
Promoting tolerance to proteolipid protein-induced experimental autoimmune encephalomyelitis through targeting dendritic cells.
Proc Natl Acad Sci U S A. 2010. 107(40):17280-5. †Corresponding and *equally contributing first author. (PubMed)

Petzold C, Riewaldt J, Koenig T, Schallenberg S, Kretschmer K.
Dendritic cell-targeted pancreatic beta-cell antigen leads to conversion of self-reactive CD4(+) T cells into regulatory T cells and promotes immunotolerance in NOD mice.
Rev Diabet Stud. 2010. 7(1):47-61. (PubMed)

Schallenberg S, Tsai PY, Riewaldt J, Kretschmer K.
Identification of an immediate Foxp3(-) precursor to Foxp3(+) regulatory T cells in peripheral lymphoid organs of nonmanipulated mice.
J Exp Med. 2010. 207(7):1393-407. (PubMed)

Feuerer M, Hill JA, Kretschmer K, von Boehmer H, Mathis D, Benoist C.
Genomic definition of multiple ex vivo regulatory T cell subphenotypes.
Proc Natl Acad Sci U S A. 2010. 107(13):5919-24. (PubMed)

2009

Nolting J, Daniel C, Reuter S, Stuelten C, Li P, Sucov H, Kim BG, Letterio JJ, Kretschmer K, Kim HJ, von Boehmer H.
Retinoic acid can enhance conversion of naive into regulatory T cells independently of secreted cytokines.
J Exp Med. 2009. 206(10):2131-9. (PubMed)

2008

Polansky JK*, Kretschmer K*, Freyer J, Floess S, Garbe A, Baron U, Olek S, Hamann A, von Boehmer H, Huehn J.
DNA methylation controls Foxp3 gene expression.
Eur J Immunol. 2008; 38(6):1654-63. *These authors contributed equally. (PubMed)

2007

Marson A*, Kretschmer K*, Frampton GM, Jacobsen ES, Polansky JK, MacIsaac KD, Levine SS, Fraenkel E, von Boehmer H, Young RA.
Foxp3 occupancy and regulation of key target genes during T-cell stimulation.
Nature. 2007; 445(7130):931-5. *These authors contributed equally. (PubMed)

2006

Kretschmer K, Apostolou I, Jaeckel E, Khazaie K, von Boehmer H.
Making regulatory T cells with defined antigen specificity: role in autoimmunity and cancer.
Immunol Rev. 2006; 212:163-9. Review. (PubMed)

Kretschmer K, Heng TS, von Boehmer H.
De novo production of antigen-specific suppressor cells in vivo.
Nat Protoc. 2006; 1(2):653-61. (PubMed)

2005

Kretschmer K, Apostolou I, Hawiger D, Khazaie K, Nussenzweig MC, von Boehmer H.
Inducing and expanding regulatory T cell populations by foreign antigen.
Nat Immunol. 2005; 6(12):1219-27 (PubMed)